Peptides / TB-500 / Australia

TB-500 in Australia

Legal status, what it is, and the listed suppliers in Australia that list it.

Legal status in Australia

Prescription only. Thymosin beta 4 is listed in Schedule 4 of the Poisons Standard (June 2026), and TB-500 is a fragment of thymosin beta 4.

As understood at 2026-09-22. Verify with the TGA.

What TB-500 is

TB-500 is a synthetic peptide corresponding to a fragment of thymosin beta-4, a naturally occurring 43-amino-acid protein involved in regulating actin, a building block of cell structure. The published research below is on the full protein, not the fragment that suppliers sell under the name TB-500.

Full TB-500 page: targets and research →

Clinical Research

Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Bock-Marquette I, Saxena A, White MD, et al. (2004). Nature. animal embryonic and postnatal cardiomyocytes in culture, then mice after coronary artery ligation
Thymosin beta 4 and the eye: the journey from bench to bedside
Sosne G (2018). Expert Opinion on Biological Therapy. review n/a (narrative review by an investigator in the field)
Thymosin β4: actin-sequestering protein moonlights to repair injured tissues
Goldstein AL, Hannappel E, Kleinman HK (2005). Trends in Molecular Medicine. review n/a (review)